Clarity Pharmaceuticals (CLRPF, $1.09) was a top loser over the last three months, falling -5 to $1.09 per share. A.I.dvisor analyzed 848 stocks in the Biotechnology Industry for the 3-month period ending April 16, 2025, and found that of them (2) exhibited an Uptrend while of them (7) demonstrated a Downtrend.